Treatment with the anti-cancer agent apitolisib has helped two patients with peritoneal mesothelioma (MPeM), a British study shows. The study, “Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy,” appeared ... Read more